Pfizer's efficiency at spending on R&D and Capex is set to look much better. Click here to see why PFE stock is a Buy.

Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is ...

Stock market investors have plenty of reasons to celebrate as 2024 comes to a close. Questions regarding the path of ...

We recently published a list of the 10 Best Stocks to Buy and Hold For 3 Years. In this article, we are going to take a look ...

Look no further than our top two stories of the year, and you’ll see that the GLP-1 craze and Big Pharma layoffs took center ...

Chances of Malaysians getting their hands on updated Covid-19 vaccines appear dim following what appears to be a lack of ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...

Part of it was the brazen manner in which it was done- right in the heart of Manhattan, point blank, with the accused, 26 ...

Dividend stocks are highly appealing to passive income investors. These stocks not only provide a consistent income stream, ...

As the hospitals continued to be inundated with COVID-19 patients and people continued to die from the SARS-CoV-2 virus, there was hope that the nightmare would end sooner rather than later.